← Home
Search
CRS Products
25 Congressional Research Service reports and publications
The 340B Drug Discount Program: Litigation Topics and Trends
2025-09-10 ·
Reports
· R48696 · HTML available · PDF available
Most-Favored-Nation Prescription Drug Pricing Executive Order: Legal Issues
2025-06-05 ·
Posts
· LSB11319 · HTML available · PDF available
The Reorganization of the U.S. Department of Health and Human Services: Selected Legal Issues
2025-05-08 ·
Posts
· LSB11311 · HTML available
Compensation for COVID-19 Vaccine Injuries
2025-04-16 ·
Reports
· R46982 · HTML available · PDF available
Medicare Part D Premium Stabilization Demonstration
2025-01-30 ·
Resources
· IF12889 · HTML available · PDF available
Fourth Circuit Holds That Certain Medicaid and State-Funded Health Plans Discriminate by Refusing to Cover Treatments for Gender Dysphoria
2024-12-18 ·
Posts
· LSB11092 · HTML available · PDF available
Administrative Procedure Act (APA) Challenges to the Medicare Drug Price Negotiation Program
2024-11-14 ·
Reports
· R48264 · HTML available · PDF available
Constitutional Challenges to the Medicare Drug Price Negotiation Program
2024-10-10 ·
Reports
· R47682 · HTML available · PDF available
State Regulation of Prescription Drug Prices: Prescription Drug Affordability Boards and Related Litigation
2024-09-04 ·
Posts
· LSB11221 · HTML available · PDF available
Private Equity Investments in Health Care: Selected Enforcement Issues
2024-08-08 ·
Posts
· LSB11215 · HTML available · PDF available
Litigation Continues Over Use of Contract Pharmacies in 340B Drug Discount Program
2024-05-23 ·
Posts
· LSB11163 · HTML available · PDF available
The Scope of ACA Section 1557: “Health Program or Activity”
2024-05-06 ·
Posts
· LSB11160 · HTML available · PDF available
The Orphan Drug Act: Legal Overview and Policy Considerations
2024-03-05 ·
Resources
· IF12605 · HTML available · PDF available
Medicare Drug Price Negotiation Under the Inflation Reduction Act: Industry Responses and Potential Effects
2023-12-08 ·
Reports
· R47872 · HTML available
Pharmacy Benefit Managers: Current Legal Framework
2023-11-20 ·
Posts
· LSB11080 · HTML available · PDF available
The Orphan Drug Act and Catalyst Pharmaceuticals, Inc., v. Becerra
2023-08-17 ·
Reports
· R47653 · HTML available · PDF available
Involuntary Civil Commitment: Fourteenth Amendment Due Process Protections
2023-05-24 ·
Reports
· R47571 · HTML available · PDF available
Implementation of the Medicare Drug Price Negotiation Program: Centers for Medicare and Medicaid Guidance and Legal Considerations
2023-05-16 ·
Reports
· R47555 · HTML available · PDF available
Selected Issues in Pharmaceutical Drug Pricing
2023-03-01 ·
Resources
· IF12272 · HTML available · PDF available
Behavioral Health Benefit Coverage and Wit v. United Behavioral Health
2022-12-21 ·
Posts
· LSB10881 · HTML available · PDF available
Implications of the HHS Notice of Proposed Rulemaking on Section 1557 and Medicare Part B
2022-11-17 ·
Posts
· LSB10860 · HTML available · PDF available
Overview of the 340B Drug Discount Program
2022-10-14 ·
Resources
· IF12232 · HTML available · PDF available
Courts Evaluate the Role of Contract Pharmacies in the 340B Drug Discount Program
2022-10-13 ·
Posts
· LSB10842 · HTML available · PDF available
Supreme Court Overturns HHS Regulation Reducing the Medicare Outpatient Drug Reimbursement Rate for 340B Hospitals
2022-09-16 ·
Posts
· LSB10821 · HTML available · PDF available
The National Vaccine Injury Compensation Program and the Office of Special Masters
2022-09-14 ·
Resources
· IF12213 · HTML available · PDF available